Nanhua Bio Medicine Co Ltd

Nanhua Bio Medicine Co Ltd

000504 · SHE · Healthcare / Biotechnology

7.85CNY-0.41 (-4.96%)

Price History

Full chart

Market Stats

Previous Close8.26
Open8.10
Day Range7.83 – 8.26
52-Week Range7.02 – 14.04
Volume10.66M
Market Cap4.10B
P/E (TTM)103.50
Forward P/E0.00
EPS0.12
Dividend Yield0.00%
Beta0.40
50-Day Avg8.88
200-Day Avg8.98

About

Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment provides stem cell and immune cell testing, storage, and technical services; as well as sales of biopharmaceutical products, such as beauty products, health supplements, and air purifiers. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business. The company was incorporated in 1991 and is headquartered in Changsha, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Yun Yang
  • Employees316
  • HeadquartersLugu Science and Technology, Changsha, China, 410205, China
  • Websitehttps://www.landfar.cn

Leadership

  • Mr. Yun YangGM & Chairman · b. 1980
  • Mr. Pengbin LinDeputy GM & CFO · b. 1973
  • Mr. Liang SuDeputy GM & Secretary of the Board · b. 1980
  • Mr. Ailong LiuDeputy General Manager · b. 1978
  • Ms. Yi ChenAccounting Supervisor & Employee Representative Director · b. 1983

Financials

Income Statement

Currency: CNY1992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue176.63M319.92M138.93M48.35M-98.39M169.94M-52.42M-30.06M21.58M175.22M249.51M255.94M273.76M222.49M227.94M319.09M197.46M178.31M151.99M90.89M76.82M26.28M18.37M13.37M67.25M67.39M95.38M134.16M175.56M156.62M200.35M136.79M134.45M415.94M
Growth (%)-+81.12%-56.57%-65.20%-303.51%+272.72%-130.84%+42.64%+171.76%+712.11%+42.40%+2.58%+6.96%-18.73%+2.45%+39.99%-38.12%-9.70%-14.76%-40.20%-15.49%-65.79%-30.09%-27.21%+402.84%+0.21%+41.53%+40.66%+30.86%-10.79%+27.92%-31.72%-1.71%+209.37%
Cost of Revenue90.66M118.55M35.55M25.18M-18.30M135.78M-12.94M20.95M21.50M87.59M139.08M141.29M162.13M144.19M158.24M257.70M170.29M158.22M117.60M71.71M48.14M27.76M13.45M11.93M45.58M50.19M35.14M53.75M79.80M46.21M72.98M44.85M44.77M324.14M
Gross Profit85.97M201.36M103.38M23.16M-80.09M34.16M-39.48M-51.01M78.12K87.63M110.43M114.65M111.63M78.30M69.70M61.38M27.17M20.09M34.39M19.19M28.68M-1.48M4.93M1.44M21.67M17.20M60.24M80.41M95.77M110.40M127.36M91.95M89.68M91.80M
Gross Margin48.67%62.94%74.41%47.91%81.40%20.10%75.32%169.67%0.36%50.01%44.26%44.80%40.78%35.19%30.58%19.24%13.76%11.27%22.63%21.11%37.33%-5.64%26.81%10.79%32.22%25.52%63.16%59.94%54.55%70.49%63.57%67.22%66.70%22.07%
Operating Expense17.71M48.56M43.96M32.27M17.46M22.34M149.30M5.99M-82.66M70.02M79.96M79.60M78.42M73.81M64.72M60.00M195.84M153.68M29.22M52.32M36.83M25.21M30.48M25.41M960.55K53.01M94.90M63.82M76.83M141.07M153.51M137.66M110.49M60.94M
Operating Income68.25M152.80M59.42M-9.10M-97.55M11.82M-188.78M-57.01M82.74M17.60M30.47M35.05M33.21M4.49M4.98M1.39M-168.67M-133.59M5.17M-33.13M-8.15M-26.69M-25.55M-23.96M20.71M-35.81M-34.66M16.59M18.94M-30.67M-26.15M-45.71M-20.81M30.86M
Operating Margin38.64%47.76%42.77%-18.83%99.15%6.95%360.14%189.61%383.50%10.05%12.21%13.69%12.13%2.02%2.19%0.43%-85.42%-74.92%3.40%-36.45%-10.62%-101.57%-139.07%-179.17%30.79%-53.14%-36.34%12.37%10.79%-19.58%-13.05%-33.42%-15.48%7.42%
EBITDA70.47M161.96M78.18M10.54M-93.21M7.43M48.27M-53.31M14.69M28.56M41.53M50.27M43.54M16.83M16.73M19.87M-155.98M-122.03M10.06M-29.30M-144.56M24.56M-20.61M-15.91M39.73M-24.44M-20.15M32.04M26.33M-10.25M-5.27M-30.59M-16.53M29.14M
EBITDA Margin39.90%50.63%56.27%21.81%94.74%4.37%-92.10%177.33%68.10%16.30%16.65%19.64%15.90%7.57%7.34%6.23%-78.99%-68.44%6.62%-32.24%-188.19%93.46%-112.17%-119.00%59.08%-36.26%-21.13%23.88%15.00%-6.55%-2.63%-22.36%-12.29%7.00%
Net Income62.96M128.80M56.35M-9.11M-96.96M10.38M-189.64M-56.62M28.26M5.09M29.04M31.85M29.80M2.05M2.23M3.67M-170.06M-134.66M6.46M-29.90M-149.23M13.80M-26.15M-21.22M21.76M-37.12M-35.19M18.81M8.15M-19.13M-12.46M-28.17M-19.85M28.83M
Net Income Margin35.64%40.26%40.56%-18.85%98.55%6.11%361.78%188.32%130.99%2.91%11.64%12.45%10.89%0.92%0.98%1.15%-86.13%-75.52%4.25%-32.90%-194.27%52.52%-142.34%-158.65%32.35%-55.08%-36.89%14.02%4.64%-12.21%-6.22%-20.60%-14.76%6.93%
R&D------------------------397.06K2.73M16.07M15.52M4.98M8.54M9.99M12.57M9.69M7.66M
R&D as % of Total Revenue------------------------0.59%4.05%16.85%11.57%2.83%5.45%4.98%9.19%7.21%1.84%
Interest Expense4.17M15.72M19.27M19.57M5.95M14.69M27.45M26.85M13.75M11.93M7.92M9.34M6.53M8.31M9.48M10.73M8.76M5.72M791.43K31.53K5.78M1.41M752.35K1.05M3.30M9.01M13.12M11.66M4.31M16.45M13.36M11.07M1.79M2.00M
Interest Expense % of Total Revenue2.36%4.91%13.87%40.48%-6.05%8.64%-52.36%-89.30%63.75%6.81%3.17%3.65%2.39%3.73%4.16%3.36%4.44%3.21%0.52%0.03%7.52%5.35%4.09%7.82%4.91%13.37%13.75%8.69%2.46%10.50%6.67%8.09%1.33%0.48%

Balance Sheet

Currency: CNY1989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets19.01M83.18M223.41M455.24M782.34M831.10M861.03M766.94M743.86M631.05M479.49M597.05M600.98M620.07M595.75M603.88M648.02M637.48M681.31M536.52M412.24M286.82M276.47M76.06M125.89M106.63M122.76M301.19M404.78M342.71M268.33M556.14M659.25M553.06M771.38M608.17M991.73M
Total Liabilities15.24M23.91M112.87M280.90M228.74M225.14M236.85M225.85M192.73M278.36M305.96M211.30M278.69M232.77M172.25M160.03M202.16M193.70M232.31M258.36M267.95M125.69M146.09M96.86M122.32M99.61M137.26M221.43M276.34M234.95M153.87M421.66M548.93M473.18M466.71M326.17M634.22M
Total Equity3.77M59.26M110.54M174.34M553.60M605.96M624.18M527.21M537.59M340.10M161.79M314.97M322.29M387.30M419.15M439.61M441.66M443.78M449.00M278.16M142.60M156.17M126.27M-22.97M1.06M4.71M-16.51M5.27M24.64M-10.25M18.41M26.57M16.64M13.77M256.94M237.10M265.75M
Cash836.99K3.85M28.33M61.07M128.99M19.43M20.60M18.71M10.16M7.36M5.49M11.52M37.98M67.72M68.24M50.98M66.86M48.58M75.72M51.00M59.13M16.01M27.62M8.23M27.92M26.72M46.79M96.42M166.58M59.01M69.39M67.04M153.00M218.15M493.81M207.36M346.77M
Total Debt8.17M5.00M75.23M200.30M135.66M135.69M177.83M175.03M164.93M163.04M152.42M58.64M133.51M185.51M130.51M120.51M164.51M159.51M170.00M118.00M43.00M1.00M15.00M1.00M1.00M1.00M50.00M135.60M160.00M89.00M50.08M13.02M52.14M80.68M44.28M24.06M-
Net Debt7.33M1.15M46.90M139.22M6.68M116.26M157.23M156.32M154.77M155.68M146.92M47.11M95.53M117.79M62.26M69.53M97.65M110.92M94.28M67.00M-16.13M-15.01M-12.62M-7.23M-26.92M-25.72M3.21M39.18M-6.58M29.99M-19.31M-54.02M-100.86M-137.46M-449.53M-183.30M-

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.32M-1.93M-3.36M34.22M15.83M55.75M13.31M11.40M717.62K9.22M-18.59M60.28M-63.95M-3.12M-4.28M-11.74M-32.60M-17.17M-14.60M-47.40M-15.19M14.52M-207.22M107.10M166.38M36.28M4.79M-115.74M
Investing Cash Flow-7.21M1.03M11.83M-74.11M-18.09M11.47M-5.30M-31.17M-1.01M17.76M-3.39M-362.39K71.96M-221.48K-88.58K-18.58M3.49M841.30K-25.61M73.32M-23.75M81.25M8.29M-30.15M-16.12M12.75M-108.33M-
Financing Cash Flow1.10M-960.90K-2.44M66.86M32.01M-66.70M-25.27M35.66M-17.99M161.33K-20.76M-49.29M-35.63M14.96M-15.03M50.00M27.90M36.40M83.01M51.09M-69.31M-85.79M196.58M9.02M-85.15M226.63M-182.91M-
Capital Expenditure113.89K707.05K127.20K2.03M251.97K7.38M2.76M1.63M1.55M680.91K2.29M367.00K1.85M221.48K88.58K23.69M276.33K12.47M4.26M1.03M9.30M2.57M4.47M31.96M16.94M5.92M18.26M5.12M
Free Cash Flow3.20M-2.64M-3.49M32.19M15.58M48.37M10.55M9.76M-829.06K8.53M-20.88M59.91M-65.80M-3.34M-4.36M-35.44M-32.88M-29.64M-18.86M-48.43M-24.49M11.95M-211.69M75.14M149.44M30.36M-13.47M-120.85M
Dividends Paid4.27M160.32K400.00K1.91M7.40M14.36M15.27M8.34M9.68M10.84M8.76M6.38M820.69K38.41K26.43K--1.60M3.15M8.79M9.13M12.41M1.12M2.12M2.40M2.29M931.46K2.37M
FCF to OCF96.56%136.58%103.78%94.06%98.41%86.77%79.26%85.67%-115.53%92.61%112.32%99.39%102.89%107.09%102.07%301.79%100.85%172.63%129.15%102.17%161.22%82.27%102.16%70.16%89.82%83.69%-280.98%104.42%
Dividend Paid to FCF133.43%-6.07%-11.46%5.95%47.47%29.69%144.76%85.46%-1167.21%126.99%-41.95%10.66%-1.25%-1.15%-0.61%---5.41%-16.68%-18.14%-37.30%103.89%-0.53%2.82%1.61%7.54%-6.92%-1.96%

Earnings

Report DateMar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 27, 2020Aug 28, 2020Oct 29, 2020Feb 4, 2021Apr 29, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 24, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 23, 2025
EPS Estimate-----------------------------------------
EPS Actual-0.01-0.01-0.01-0.03-0.01-0.03-0.010.12-0.02-0.02-0.03-0.05-0.02-0.03-0.02-0.04-0.02-0.03-0.020.12-0.01-0.00-0.000.040.00-0.02-0.01-0.030.000.01-0.01-0.04-0.01-0.020.03-0.09-0.01-0.02-0.00-0.03-0.01
Surprise-----------------------------------------
Timing------------------------------------After-hours---After-hours

Key Statistics & Ratios

Market Cap4.10B
Enterprise Value4.12B
Trailing P/E103.50
Forward P/E0.00
PEG Ratio0.00
Price / Sales6.21
Price / Book15.50
EPS0.12
Book Value0.823
Revenue (TTM)660.26M
Gross Profit (TTM)88.03M
EBITDA33.83M
Profit Margin5.80%
Operating Margin-7.35%
Return on Equity10.53%
Return on Assets2.04%
Shares Outstanding330.02M
Shares Float222.32M
Beta0.40
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20041×
0.02Apr 23, 2004
19931×
0.02Jun 14, 1993

Stock Splits

  • Jan 15, 200713:10
  • Jun 13, 19951.1:1
  • Jun 27, 19941.4:1
  • Jun 14, 199313:10